Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1513 results found
2022 ∙ Ahmed, T. I. Rishi, S. Irshad, S. Aggarwal, J. Happa, K. Mansoor, S.
Inactivated vaccine Covaxin/BBV152: A systematic review
All age groups COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Zheng, X. Gao, F. Wang, L. Meng, Y. Ageno, W. Qi, X.
Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis
Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Wu, X. X. Yao, J. J. Qian, J. Huang, Q. F. Deng, T. Xu, S. Q. Wang, H. F. Li, Q. Peng, J. C. Yi, Y. Li, N. Huang, Y. Liu, X. R.
Incidence of adverse reactions to COVID-19 vaccination: A meta-analysis of randomized controlled trials
Children Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Bayati, M. Noroozi, R. Ghanbari-Jahromi, M. Jalali, F. S.
Inequality in the distribution of Covid-19 vaccine: a systematic review
All age groups COVID-19 Logistics Ethical issues
Rating:
Not applicable
2022 ∙ Ding, Y. Ge, Y.
Inflammatory myopathy following coronavirus disease 2019 vaccination: A systematic review
Adults Older adults COVID-19 Safety
Rating:
Low
2022 ∙ Kapoula, G. V. Vennou, K. E. Bagos, P. G.
Influenza and Pneumococcal Vaccination and the Risk of COVID-19: A Systematic Review and Meta-Analysis
All age groups COVID-19 Influenza Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Wu, H. H. L. Shenoy, M. Kalra, P. A. Chinnadurai, R.
Intrinsic Kidney Pathology in Children and Adolescents Following COVID-19 Vaccination: A Systematic Review
Children Adolescents COVID-19 Safety
Rating:
Critically low
2022 ∙ Hameed, I. Khan, M. O. Nusrat, K. Mahmood, S. Nashit, M. Malik, S. Siddiqui, O. M. Samad, S. A. Marsia, S. Usman, M. S. Siddiqi, T. J.
Is it safe and effective to administer COVID-19 vaccines during pregnancy? A systematic review and meta-analysis
Adults Pregnant women COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Mirmosayyeb, O. Moases Ghaffary, E. Mazdak, M. Bagheri, Z. Bagherieh, S. Shaygannejad, V.
Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Cascio Rizzo, A. Giussani, G. Agostoni, E. C.
Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature
Adults Older adults COVID-19 Safety
Rating:
Critically low
Loading...